|
The Chapter has been in ongoing discussions with our members and MassHealth since the issue with inhaled fluticasone began and we are aware that Asmanex shortages complicated matters even more. We are happy to report that MassHealth has eliminated prior authorization requirements for fluticasone for all children under 12 years old.
The ACOs should be adjusting their requirements as well. See the announcements below. We thank all the pediatricians and pediatric pulmonologists who have continued to advocate with all payers.
Here are the published pharmacy facts as well as the e-prescriber letter on the fluticasone HFA changes:
Pharmacy facts: https://www.mass.gov/doc/pharmacy-facts-225-april-11-2024-0/download
e-prescriber letter: https://www.mass.gov/doc/issue-1-april-2024-0/download
| 
